235 related articles for article (PubMed ID: 27623947)
1. Investigation of gene-diet interactions in the incretin system and risk of type 2 diabetes: the EPIC-InterAct study.
InterAct Consortium
Diabetologia; 2016 Dec; 59(12):2613-2621. PubMed ID: 27623947
[TBL] [Abstract][Full Text] [Related]
2. Comparing olive oil and C4-dietary oil, a prodrug for the GPR119 agonist, 2-oleoyl glycerol, less energy intake of the latter is needed to stimulate incretin hormone secretion in overweight subjects with type 2 diabetes.
Mandøe MJ; Hansen KB; Windeløv JA; Knop FK; Rehfeld JF; Rosenkilde MM; Holst JJ; Hansen HS
Nutr Diabetes; 2018 Jan; 8(1):2. PubMed ID: 29330461
[TBL] [Abstract][Full Text] [Related]
3. Role of TCF7L2 risk variant and dietary fibre intake on incident type 2 diabetes.
Hindy G; Sonestedt E; Ericson U; Jing XJ; Zhou Y; Hansson O; Renström E; Wirfält E; Orho-Melander M
Diabetologia; 2012 Oct; 55(10):2646-2654. PubMed ID: 22782288
[TBL] [Abstract][Full Text] [Related]
4. Interaction between genes and macronutrient intake on the risk of developing type 2 diabetes: systematic review and findings from European Prospective Investigation into Cancer (EPIC)-InterAct.
Li SX; Imamura F; Ye Z; Schulze MB; Zheng J; Ardanaz E; Arriola L; Boeing H; Dow C; Fagherazzi G; Franks PW; Agudo A; Grioni S; Kaaks R; Katzke VA; Key TJ; Khaw KT; Mancini FR; Navarro C; Nilsson PM; Onland-Moret NC; Overvad K; Palli D; Panico S; Quirós JR; Rolandsson O; Sacerdote C; Sánchez MJ; Slimani N; Sluijs I; Spijkerman AM; Tjonneland A; Tumino R; Sharp SJ; Riboli E; Langenberg C; Scott RA; Forouhi NG; Wareham NJ
Am J Clin Nutr; 2017 Jul; 106(1):263-275. PubMed ID: 28592605
[No Abstract] [Full Text] [Related]
5. Dietary fibre and incidence of type 2 diabetes in eight European countries: the EPIC-InterAct Study and a meta-analysis of prospective studies.
InterAct Consortium
Diabetologia; 2015 Jul; 58(7):1394-408. PubMed ID: 26021487
[TBL] [Abstract][Full Text] [Related]
6. The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men.
Pilgaard K; Jensen CB; Schou JH; Lyssenko V; Wegner L; Brøns C; Vilsbøll T; Hansen T; Madsbad S; Holst JJ; Vølund A; Poulsen P; Groop L; Pedersen O; Vaag AA
Diabetologia; 2009 Jul; 52(7):1298-307. PubMed ID: 19288077
[TBL] [Abstract][Full Text] [Related]
7. Physiology of incretins and loss of incretin effect in type 2 diabetes and obesity.
Opinto G; Natalicchio A; Marchetti P
Arch Physiol Biochem; 2013 Oct; 119(4):170-8. PubMed ID: 23859800
[TBL] [Abstract][Full Text] [Related]
8. Carriers of the TCF7L2 rs7903146 TT genotype have elevated levels of plasma glucose, serum proinsulin and plasma gastric inhibitory polypeptide (GIP) during a meal test.
Gjesing AP; Kjems LL; Vestmar MA; Grarup N; Linneberg A; Deacon CF; Holst JJ; Pedersen O; Hansen T
Diabetologia; 2011 Jan; 54(1):103-10. PubMed ID: 20957343
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetic aspects of the treatment of Type 2 diabetes with the incretin effect enhancers.
Tkáč I; Gotthardová I
Pharmacogenomics; 2016 May; 17(7):795-804. PubMed ID: 27166975
[TBL] [Abstract][Full Text] [Related]
10. Genetic determinants of circulating GIP and GLP-1 concentrations.
Almgren P; Lindqvist A; Krus U; Hakaste L; Ottosson-Laakso E; Asplund O; Sonestedt E; Prasad RB; Laurila E; Orho-Melander M; Melander O; Tuomi T; Holst JJ; Nilsson PM; Wierup N; Groop L; Ahlqvist E
JCI Insight; 2017 Nov; 2(21):. PubMed ID: 29093273
[TBL] [Abstract][Full Text] [Related]
11. TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action.
Villareal DT; Robertson H; Bell GI; Patterson BW; Tran H; Wice B; Polonsky KS
Diabetes; 2010 Feb; 59(2):479-85. PubMed ID: 19934000
[TBL] [Abstract][Full Text] [Related]
12. Small intestinal glucose exposure determines the magnitude of the incretin effect in health and type 2 diabetes.
Marathe CS; Rayner CK; Bound M; Checklin H; Standfield S; Wishart J; Lange K; Jones KL; Horowitz M
Diabetes; 2014 Aug; 63(8):2668-75. PubMed ID: 24696447
[TBL] [Abstract][Full Text] [Related]
13. Whole-grain consumption and transcription factor-7-like 2 ( TCF7L2) rs7903146: gene-diet interaction in modulating type 2 diabetes risk.
Fisher E; Boeing H; Fritsche A; Doering F; Joost HG; Schulze MB
Br J Nutr; 2009 Feb; 101(4):478-81. PubMed ID: 19149908
[TBL] [Abstract][Full Text] [Related]
14.
Srinivasan S; Kaur V; Chamarthi B; Littleton KR; Chen L; Manning AK; Merino J; Thomas MK; Hudson M; Goldfine A; Florez JC
Diabetes Care; 2018 Mar; 41(3):554-561. PubMed ID: 29326107
[TBL] [Abstract][Full Text] [Related]
15. Glycemia determines the effect of type 2 diabetes risk genes on insulin secretion.
Heni M; Ketterer C; Thamer C; Herzberg-Schäfer SA; Guthoff M; Stefan N; Machicao F; Staiger H; Fritsche A; Häring HU
Diabetes; 2010 Dec; 59(12):3247-52. PubMed ID: 20802253
[TBL] [Abstract][Full Text] [Related]
16. Interplay between genetic predisposition, macronutrient intake and type 2 diabetes incidence: analysis within EPIC-InterAct across eight European countries.
Li SX; Imamura F; Schulze MB; Zheng J; Ye Z; Agudo A; Ardanaz E; Aune D; Boeing H; Dorronsoro M; Dow C; Fagherazzi G; Grioni S; Gunter MJ; Huerta JM; Ibsen DB; Jakobsen MU; Kaaks R; Key TJ; Khaw KT; Kyrø C; Mancini FR; Molina-Portillo E; Murphy N; Nilsson PM; Onland-Moret NC; Palli D; Panico S; Poveda A; Quirós JR; Ricceri F; Sluijs I; Spijkerman AMW; Tjonneland A; Tumino R; Winkvist A; Langenberg C; Sharp SJ; Riboli E; Scott RA; Forouhi NG; Wareham NJ
Diabetologia; 2018 Jun; 61(6):1325-1332. PubMed ID: 29549418
[TBL] [Abstract][Full Text] [Related]
17. Common variants in the hERG (KCNH2) voltage-gated potassium channel are associated with altered fasting and glucose-stimulated plasma incretin and glucagon responses.
Engelbrechtsen L; Mahendran Y; Jonsson A; Gjesing AP; Weeke PE; Jørgensen ME; Færch K; Witte DR; Holst JJ; Jørgensen T; Grarup N; Pedersen O; Vestergaard H; Torekov S; Kanters JK; Hansen T
BMC Genet; 2018 Mar; 19(1):15. PubMed ID: 29548277
[TBL] [Abstract][Full Text] [Related]
18. Incretin dysfunction in type 2 diabetes: clinical impact and future perspectives.
Ahrén B
Diabetes Metab; 2013 May; 39(3):195-201. PubMed ID: 23643349
[TBL] [Abstract][Full Text] [Related]
19. Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response.
Tura A; Bagger JI; Ferrannini E; Holst JJ; Knop FK; Vilsbøll T; Mari A
Nutr Metab Cardiovasc Dis; 2017 Dec; 27(12):1123-1129. PubMed ID: 29162361
[TBL] [Abstract][Full Text] [Related]
20. Incretin hormones: Their role in health and disease.
Nauck MA; Meier JJ
Diabetes Obes Metab; 2018 Feb; 20 Suppl 1():5-21. PubMed ID: 29364588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
